Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-14-001297
Filing Date
2014-04-11
Accepted
2014-04-11 15:08:45
Documents
1
Period of Report
2014-04-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1414757.html 4  
1 OWNERSHIP DOCUMENT zk1414757.xml 4 3850
  Complete submission text file 0001178913-14-001297.txt   5470
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 415 EAST 37TH STREET APT 36C NEW YORK NY 10016
Business Address
Berelowitz Michael (Reporting) CIK: 0001493383 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 14759742